June 16, 2016

Learn How DrugDev has Become the Fastest Growing Clinical Trials Technology Company by Transforming Site Selection, Activation, Payments, and Engagement at New Webinar

Featuring a unique perspective on the impact of clinical technology on global sites provided by Hugo Stephenson, MD, an active principal investigator (and DrugDev Executive Chairman) from his native Australia

DrugDev is known throughout the pharmaceutical industry as an innovative company driven to help the world do more trials together through standardization, collaboration and a beautiful technology experience on its unified platform.

Because the industry is so accustomed to products intended for a specific and often siloed areas, the concept of a unified platform that provides numerous connected solutions is unique enough even people familiar with DrugDev may not know all of the challenges the company solves.

On June 22 at 10am ET, DrugDev will host a complimentary webinar (register here) and platform demo to provide an overview of the solutions currently being used by 9 of the top 10 pharmaceutical companies, 4 of the top 5 CROs, and revolutionary industry collaborations such as the TransCelerate Investigator Registry and the Investigator Databank. Attendees will…

  • Learn the impact of clinical systems on global sites from Hugo Stephenson, MD, an active principal investigator in his native Australia who also serves as DrugDev’s Executive Chairman and heads up the company’s Innovation Lab
  • Understand how sponsors use technology to solve frustrations with:

— Global site payments
— Site identification
— Master data management (featuring the DrugDev Golden Number)
— Site activation and engagement
— Learning management

  • Experience a live demo of the unified, cloud-based DrugDev SaaS platform
  • Preview upcoming solutions including an intuitive patient portal and a mobile app to help sites easily conduct patient eligibility screening
  • Explore proven results of DrugDev’s platform for enabling faster, smarter clinical trials through brief client case studies
  • Participate in the conversation with interactive polls and an engaging Q&A session

Webinar: What Does DrugDev Do?
Date: June 22, 2016
Time: 10:00-11:00 am ET
This webinar is complimentary.

About the Presenters

Hugo Stephenson, MD, Principal Investigator, Executive Chairman – Hugo is a doctor, technologist, inventor and entrepreneur in the clinical trials industry. He recently returned to his roots as a physician and active Principal Investigator in his native Australia, fueling his passion for advancing research.

Brett Kleger, Chief Commercial Officer – Brett leads DrugDev’s commercial strategy and development including bringing new capabilities to market and ensuring the success of DrugDev solutions and the client experience.

Eric Silberstein, President, DrugDev TrialNetworks – Eric passionately believes technology can and must radically enhance clinical trial operations to ensure a steady stream of innovations addressing major health challenges. His work on dozens of trials and his background in technology and online collaboration fueled the vision behind the DrugDev TrialNetworks platform.

About DrugDev
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at